Researchers in dermatology at Lund University in Sweden believe they have cracked the mystery of why we are able to quickly prevent an infection from spreading uncontrollably in the body during wounding. They believe this knowledge may be of clinical significance for developing new ways to counteract bacteria.
“Perhaps we don’t need to kill them with antibiotics but simply gather them so that the body can better take care of the infection”, say researchers Jitka Petrlova (lead author of the article) and Artur Schmidtchen, Professor in Dermatology and Venereology, Lund University. The study was conducted in close collaboration with their colleagues in Lund, Copenhagen and Singapore, and has been published in the scientific journal Proceedings of the National Academy of Sciences (PNAS).
The researchers have discovered that fragments of thrombin – a common blood protein which can be found in wounds – can aggregate both bacteria and their toxins; something they did not see in normal blood plasma. The aggregation takes place quickly in the wound and causes bacteria and endotoxins not only to gather but also to be “eaten” by the body’s inflammatory cells.
“This way, the body avoids a spread of the infection. We believe this to be a fundamental mechanism for taking care of both bacteria and their toxins during wound healing”, says Jitka Petrlova and continues;
“Our discovery links aggregation and amyloid formation to our primary defence against infections – our innate immunity. It is well known that various aggregating proteins can cause amyloid disease, in skin or internal organs, such as the brain. Therefore, a mechanism that is supposed to protect us from infections, can sometimes be over-activated and lead to degenerative diseases.”
Artur Schmidtchen, who has conducted research in the field of innate immunity for over 20 years, is pleased with the results of the study.
“I have always been fascinated by how nature has effectively created different defence mechanisms, and wound healing provides a rich source of new discoveries. The ability to effectively heal wounds is of evolutionary significance to our survival. Compared to antibiotics, innate immunity has been around for millions of years – and I think we should consider the application of these concepts in an era of increasing antibiotic resistance.”
The Latest on: Innate immunity
- Immune Design: Can This Small Oncology Play Deliver? on September 18, 2018 at 8:30 am
The drug activates innate and adaptive immunity in the tumor microenvironment to generate an immune response against the tumor's preexisting, diverse set of antigens. G100 is a product of the ... […]
- Newly discovered enzyme is 'firing pin' for plant immunity on September 17, 2018 at 12:30 pm
Plant immunity has some important differences ... Plants have a large repertoire of these innate immune receptors: the small laboratory plant Arabidopsis, for example, has about 600 receptors ... […]
- Innate Pharma reports first half 2018 financial results and business update on September 13, 2018 at 10:01 pm
Innate Pharma specializes in immuno-oncology, a new therapeutic field that is changing cancer treatment by mobilizing the power of the body's immune system to recognize and kill cancer cells. […]
- Open access and its global reach: Thirumala-Devi Kanneganti and Amal Amer lead new Microbes and Innate Immunity specialty on September 13, 2018 at 12:06 am
Hailed as one of the world’s most highly-cited researchers, says her aim as Chief Editor is to provide a common platform for researchers working on diverse aspects of antimicrobial innate immunity. On ... […]
- Innate PHARMA announces enrollment of first patient in the phase i study of IPH5401 in combination with durvalumab (IMFINZI®) in solid tumors on September 12, 2018 at 2:14 am
Part of the innate immune system, these types of cells promote tumor growth by secreting inflammatory mediators, immunosuppressive cytokines and angiogenic factors. They potently suppress T and NK cel... […]
via Google News and Bing News